Thymosin beta4 promotes matrix metalloproteinase expression during wound repair

Effective wound healing requires not just building new tissue but also breaking down and remodeling damaged structures. This study by Philp, Scheremeta, Sibliss, and colleagues, published in the Journal of Cellular Physiology, investigated how thymosin beta-4 facilitates this critical remodeling phase of wound repair.

The researchers examined thymosin beta-4's effects on matrix metalloproteinase (MMP) expression in excised dermal wounds and in cultured wound-repair cells, including keratinocytes, endothelial cells, and fibroblasts. They also identified the specific region of the thymosin beta-4 molecule responsible for MMP induction.

The findings demonstrated that thymosin beta-4 substantially increased MMP-2 and MMP-9 levels in excised dermal wounds by just day 2 post-injury. When applied to cultured cells, the peptide dose-dependently elevated MMP-1, MMP-2, and MMP-9 secretion in a cell-specific manner. The researchers identified the central actin-binding domain (amino acids 17-23) as the active region responsible for MMP induction.

This study reveals a key mechanism behind TB-500's wound-healing capabilities. Matrix metalloproteinases are essential enzymes for clearing damaged extracellular matrix and creating space for new tissue growth. By upregulating these enzymes early in the healing process, thymosin beta-4 accelerates the transition from injury to active repair. This mechanism complements its known anti-inflammatory and angiogenic effects, explaining why TB-500 is such an effective promoter of tissue healing.